Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M258Revenue (TTM) $M28.9Net Margin (%)-241.6Altman Z-Score-1.6
Enterprise Value $M189EPS (TTM) $-2.8Operating Margin %-251.9Piotroski F-Score1
P/E(ttm)--Beneish M-Score4.3Pre-tax Margin (%)-241.4Higher ROA y-yN
Price/Book2.110-y EBITDA Growth Rate %--Quick Ratio5.6Cash flow > EarningsN
Price/Sales8.95-y EBITDA Growth Rate %--Current Ratio5.9Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-25.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-44.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M24.8ROIC % (ttm)-134.0Gross Margin Increase y-yY

Gurus Latest Trades with ZGNX

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ZGNX is held by these investors:



ZGNX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
TANNENBAUM RENEE PDirector 2017-03-16Buy5,000$11-5.45view
HAWLEY ROGERDirector 2015-12-15Buy10,000$13.74-24.31view
HAWLEY ROGERDirector 2015-12-15Buy10,000$13.74-24.31view
TANNENBAUM RENEE PDirector 2015-12-03Buy5,000$15.4-32.47view
HAWLEY ROGERDirector 2015-06-16Buy6,250$12.72-18.24view
HAWLEY ROGERCEO 2015-03-16Buy17,500$10.48-0.76view
GARNER CAM LDirector 2014-06-13Buy3,750$13.28-21.69view
Shively Richard ScottChief Commercial Officer 2014-06-03Sell2,404$16.8-38.1view
RHOADS ANN DEVP, CFO, Treasurer & Sec. 2014-06-03Sell2,404$16.8-38.1view
HAWLEY ROGERCEO 2014-06-03Sell3,135$16.8-38.1view

Press Releases about ZGNX :

Quarterly/Annual Reports about ZGNX:

News about ZGNX:

Articles On GuruFocus.com
Analysts Weigh in on Zogenix in Light of Selling Zohydro Mar 12 2015 
Weekly CFO Buys Highlight: NGL, UNTK, ZGNX, VTSS, RVSB Dec 24 2012 
(ZGNX) CEO Roger Hawley buys 10,000 Shares Dec 06 2010 

More From Other Websites
Zogenix, Inc. :ZGNX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Mar 20 2017
Zogenix, Inc. :ZGNX-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017 Mar 15 2017
ZOGENIX, INC. Financials Mar 15 2017
Zogenix to Participate in the Oppenheimer 27th Annual Healthcare Conference Mar 15 2017
ZOGENIX, INC. Files SEC form 10-K, Annual Report Mar 10 2017
Zogenix reports 4Q loss Mar 09 2017
Zogenix reports 4Q loss Mar 09 2017
ZOGENIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Mar 09 2017
Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results Mar 09 2017
Q4 2016 Zogenix Inc Earnings Release - After Market Close Mar 09 2017
Zogenix to Release Fourth Quarter and Full-Year 2016 Financial Results and Host Conference Call and... Mar 02 2017
Zogenix Receives Orphan Drug Designation in the European Union for ZX008 in Lennox Gastaut Syndrome Mar 01 2017
ZOGENIX, INC. Files SEC form 8-K, Other Events Mar 01 2017
Zogenix to Participate in the 2017 RBC Capital Markets Healthcare Conference Feb 15 2017
Zogenix Announces Initiation of Clinical Efficacy Portion of Study 1504 for ZX008 in Dravet Syndrome Feb 13 2017
Zogenix to Participate in the Leerink Partners 6th Annual Global Healthcare Conference Feb 08 2017
ZOGENIX, INC. Files SEC form 8-K, Other Events Jan 30 2017
Zogenix Announces Issuance of U.S. Patent for ZX008 in Dravet Syndrome Jan 30 2017
Blog Coverage Novartis Announced Buyback of Shares Worth $5 Billion; Considers Strategic Options for... Jan 26 2017
ZOGENIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Jan 09 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)